Use this form to request a free consultation with a qualified attorney near you.
ATTORNEY ADVERTISING - Gacovino, Lake & Associates, P.C.
270 West Main Street
Sayville, NY 11782
Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private.
800-889-3898
Byetta® warnings regarding potential side effects have changed twice already since the introduction of this Type 2 diabetes treatment in 2005. The most serious Byetta® warnings concern the a potential risk of pancreatitis, a severe inflammation of the pancreas. Other Byetta® warnings regard matters such as:
In fact, the packaging that accompanies Byetta® injection pens has very lengthy, extensive and detailed Byetta® warnings and precautions section. Byetta® is to be prescribed only as an adjunctive treatment for Type 2 diabetes mellitus in patients who are also taking other specific diabetes drugs. Some of the additional Byetta® warnings are:
Perhaps the most serious of the Byetta® warnings is the statement about pancreatitis. The U.S. Food and Drug Administration (FDA) has required the marketers of the Byetta® drug — Amylin and Eli Lilly Co. — to "upgrade" the Byetta® warning about the risk of pancreatitis that accompanies treatment with this product. The most recent upgrade of the pancreatitis/Byetta® warning took place in the fall of 2008; this followed reports of deaths due to pancreatitis among Byetta® users.
Contact us if you believe you have been harmed by Byetta®.